Thuy Le, MD, Dphil

Le, Thuy_2015_120

Dr. Thuy Le is an Associate Professor of Medicine at Duke University, an Adjunct Associate Professor of Medicine at the University of Hawaii and a Visiting Fellow at the Oxford University Clinical Research Unit in Vietnam. She leads a research program to improve HIV clinical outcomes in Southeast Asia by mitigating HIV drug resistance development and developing novel diagnostics and treatment strategies for a leading HIV-associated opportunistic infection caused by the dimorphic fungus Talaromyces marneffei. She led the IVAP clinical trial in talaromycosis treatment that demonstrated the superiority of amphotericin B over itraconazole in reducing deaths. The study has redefined international treatment recommendations for this important endemic mycosis and calls for amphotericin to be made widely available in Asia. She is a Member of the Program Committee for the Asia Pacific AIDS and Co-Infection Conference, Member of several WHO Guidelines Committees on Management of HIV, Member of the NIH/CDC/HIVMA/IDSA Guidelines Committee on Opportunistic Infections, and a Coordinator of the European Confederation of Medical Mycology Guidelines for Endemic Mycoses. She has published in the New England Journal of Medicine, Lancet, Clinical Infectious Diseases, AIDS, and Antiviral Therapy.

Be Sociable, Share!